Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
University of Michigan Rogel Cancer Center
MPN Research Foundation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Ascentage Pharma Group Inc.
UNC Lineberger Comprehensive Cancer Center
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Astex Pharmaceuticals, Inc.
City of Hope Medical Center
Columbia University
Takeda
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Rush University Medical Center
Memorial Sloan Kettering Cancer Center
Xencor, Inc.
Rutgers, The State University of New Jersey
Northwestern University
Incyte Corporation
Roswell Park Cancer Institute